- Home
- Companies
- micronesia
- viral vector
Refine by
Viral Vector Suppliers Near Micronesia
53 companies found
Premium
based inFramingham, MASSACHUSETTS (USA)
SCIEX empowers you to solve the most impactful analytical challenges in quantitation and characterization in environmental testing. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field ...
Perform consistent and compliant biotherapeutics characterization faster than ever. With the PA 800 Plus system, you can confidently safeguard the success of your biologics. Run multiple characterizations from a single system that biopharma labs ...
based inDurham, NORTH CAROLINA (USA)
Welcome to Patheon. With a commitment to quality, scientific excellence and exceptional customer experiences. Patheon is a leading provider of drug substance and drug product services for the global biopharmaceutical industry. Patheon’s global ...
From initial inquiry through development, manufacturing, testing and product release, quality is paramount. Our in-house quality and validation teams provide a range of assay development, testing, and analytical ...
based inTurku, FINLAND
Biovian is a Bio-CDMO that provides services to biotech companies developing innovative gene therapies or biopharmaceuticals. Our goal is to turn ideas into products by taking client projects from the laboratory bench to the clinic. To do so we ...
Adenoviruses are attractive tools for gene therapy, including immuno-oncology, because of their well-defined biology and characteristics including the possibility for large gene inserts. Biovian has proven expertise in adenovirus vector process ...
based inLeipzig, GERMANY
c-LEcta is a global biotechnology company specializing in the development, production and distribution of enzyme products. The company uses world-class enzyme engineering and production technologies to provide its partners in the food and ...
It is applied for the degradation of undesired DNA and RNA during the manufacturing of biopharmaceutical products – namely viral ...
based inCranbury, NEW JERSEY (USA)
Advancing an integrated pipeline of genetic therapies that correct the root cause of complex and rare life-threatening childhood disorders. Our mission is to develop first-in-class and best-in-class, curative gene therapies for patients with ...
The LVV platform is ideal for modifying hematopoietic stem cells (HSCs) to address disorders affecting the bone marrow. The LVV transduction process occurs ex vivo (outside the body), which ensures that the gene has been properly ...
based inWien, AUSTRIA
BlueSky Immunotherapies GmbH (Ltd.) is a clinical-stage biotech company. The company’s business is based on its own proprietary, novel technology platform for interferon-inducing viral vectors (delNS). Interferons have immunostimulatory and ...
The high level of interferon induced by the delNS vector activates immunological defence reactions against cancer. It also stimulates the production of antiviral ...
based inBothell, WASHINGTON (USA)
AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics (using mammalian and microbial systems), mRNA, pDNA, viral vector and cell therapy products, from ...
AGC Biologics has been manufacturing plasmid DNA (pDNA) for over 10 years. We are experienced in both clinical and commercial pDNA manufacturing. AGC Biologics has expanded its capabilities by extending services in hosts and plasmids (low and high ...
based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
Four transgenes: Producing an anti-FAP bispecific plus cytokines/chemokines. Currently in clinical trials in the US and UK. See our clinical trials page for more information. The aim of this study is to characterise the safety, tolerability and ...
based inOxford, UNITED KINGDOM
Vaccitech is a clinical stage T cell immunotherapy and vaccine company developing products to treat and prevent infectious disease and cancer. The company’s proprietary heterologous prime-boost platform comprises Chimpanzee Adenovirus Oxford ...
based inGrove City, OHIO (USA)
Forge is developing innovative gene therapies that aim to help patients suffering from devastating rare diseases. Forge is building capacity to directly address the growing demand for gene therapy manufacturing. Forge is currently building the ...
based inHalle, GERMANY
Navigo Proteins is a successful and steadily growing, privately held protein engineering company, which develops best-in-class custom precision affinity ligands, based on selected protein scaffolds. We partner with pharma, biotech and life science ...
In conventional biologics production, sequential multi-step downstream chromatography procedures impact, more than any other factor, overall manufacturing costs, process development and manufacturing timelines. Additionally, they pose a continuing ...
based inGent, BELGIUM
RheaVita markets an innovative continuous freeze-drying technology for (bio)pharmaceutical products. Our manufacturing approach saves companies time and money, guarantees product quality and offers the supply chain greater flexibility, compared to ...
based inWest Caldwell, NEW JERSEY (USA)
Alfa Wassermann Separation Technologies (AWST), a division of Alfa Wassermann Inc., for over 60 years the supplier whose singular purpose has been the support of bioprocess and pharmaceutical industries by providing expertise in continuous flow UCF ...
The AW Promatix 1000™ is designed to develop protocols for the separation, fractionation and concentration of viral vectors, virus-like particles, viruses, viral and bacterial vaccines, ...
based inSeattle, WASHINGTON (USA)
Universal Cells is a Seattle-based company that is producing engineered stem cell lines that can avoid rejection and be used in allogeneic cell therapy treatments for the people who need them. One Cell, Many Therapies. Universal Cells edits genes ...
Universal Cells uses recombinant Adeno-Associated Virus (rAAV)-mediated gene editing to engineer chromosomal genes without the use of genotoxic nucleases. Serotype 3B rAAV vectors efficiently infect pluripotent stem cells and their single-stranded ...
based inMadison, WISCONSIN (USA)
Mirus continued the development of a wide range of non-viral delivery technologies using proteins, polymers, and lipids in conjunction with novel chemistries that provided unique nucleic acid delivery capabilities. Our work at Mirus Bio began with a ...
TransIT-VirusGEN Transfection Reagent is designed to enhance delivery of packaging and transfer plasmids to adherent and suspension HEK 293 cell types to increase recombinant adeno-associated virus (AAV) and lentivirus ...
based inOxford, UNITED KINGDOM
The Native Antigen Company has developed a proprietary HEK293 mammalian expression system (VirtuE) for expression of recombinant proteins. The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease ...
This product is a concentrated source of highly-purified human Adenovirus type 11 particles (wild-type) from a lysate of optimally-infected 293 cells. Following double CsCl gradient purification with DNase treatment and dialysis, our Ad11 ...
based inNewark, CALIFORNIA (USA)
ACD - a Bio-Techne brand, shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and ...
Application of RNAscope™ ISH in our Good Clinical Laboratory Practices (GCLP) compliant Professional Assay Services laboratory. RNAscope is the only assay that can specifically detection engineered cell therapies and measure target engagement ...
based inVienna, AUSTRIA
A spin-off from the University of Veterinary Medicine Vienna, ViruSure was founded in 2005 by Dr. Andy Bailey to offer a range of biosafety testing services to biopharmaceutical product manufacturers. Since 2008, ViruSure’s in vitro and molecular ...
Gene therapy has brought hope to many diseases with unmet clinical need. The potential to permanently cure the patient through replacement of a defective gene with a healthy gene underscores the surge of interest in this exciting biopharma ...
based inMorrisville, NORTH CAROLINA (USA)
Locus is a clinical-stage biotechnology company developing precision medicines for therapeutic indications across infectious disease and inflammatory diseases. Once revolutionary, antibiotics are interfering with the effectiveness of novel, ...
We built a world-class biologics manufacturing facility, enabling the manufacture of our precision therapeutics while providing the capability to also manufacture gene therapy vectors and other advanced biologics. Our facility ...
based inAlpharetta, GEORGIA (US) (USA)
Clearside Biomedical is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). The platform provides an in-office, repeatable, non-surgical procedure, offering targeted ...
We believe our platform offers the potential for safer, targeted ocular gene therapy without some of the risks of surgery and subretinal administration. Suprachoroidal administration of gene therapy could ultimately enhance access to care because it ...